CFN Exclusive Interview: MedMen Becomes Canada’s Next Billion Dollar Cannabis Listing -- CFN Media


SEATTLE, May 29, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of a CEO video interview and article discussing MedMen Enterprises (CSE:MMEN), a California-based cannabis retailer that’s well-known for its sleek Apple Store-like retail locations across the United States. The company has finalized its reverse takeover and today is becoming one of the largest publicly-traded cannabis firms in the world.

The company is listing on the Canadian Securities Exchange, or CSE, following its reverse takeover of Ladera Ventures Corp. It is one of the first U.S. marijuana companies to list on the CSE. U.S. marijuana companies are currently barred from the TSX, Nasdaq and NYSE. The exposure on the CSE gives MedMen access to retail investors on a global scale and could fuel its already robust growth pattern.

Unique Experience

MedMen operates 12 licensed retail outlets in California, New York, and Nevada, including a 2,000 sq. ft. flagship store on New York City’s Fifth Avenue and another location on Santa Monica Boulevard in West Hollywood. In addition to dispensary operations, the company owns a 45,000 sq. ft. state of the art cultivation facility in Nevada and has broken ground on another in California to expand its cultivation operations.

MedMen has taken the cannabis buying experience a long way from back-alley transactions just a few years ago. Its dispensaries are more akin to Apple Stores in terms of their bright and open architecture, as well as knowledgeable staff members in memorable red T-shirts. Management’s goal is to destigmatize cannabis and make mainstream adults feel comfortable purchasing product and carrying it out the door in the open.

“MedMen’s vision is simple but revolutionary: cannabis as a consumer product,” said MedMen Co-founder and CEO Adam Bierman. “For the better part of a decade we have been singularly focused on that vision – creating the systems and infrastructure that raise the bar on product quality and safety and providing a retail shopping experience that is second to none. By transitioning to a publicly-traded company, MedMen gives public investors a ground-floor opportunity to participate in the enormous and untapped potential of the fastest growing industry in the United States.”

Growing Footprint

MedMen is primarily focused on acquiring top real estate to ensure that it will remain compliant with laws prohibiting locations close to schools, churches, or parks, as well as increase the reputability of its brand as a top-shelf option in major metro markets. The goal is to expand into these major markets as quickly as possible to build up a competitive edge against competitors that have been rolling out slowly in states like Colorado.

At the same time, the company recently partnered with Cronos Group Inc. to create a joint venture that will develop products and open MedMen-branded locations across Canada when recreational cannabis is legalized this summer. The move should help diversify operations and significantly increase revenue as it competes with the primarily mail-order industry that has built up in Canada around licensed producers.

Compelling Investment

With a pre-money valuation of $1.65 billion, MedMen could immediately become one of Canada’s ten largest cannabis companies and the most valuable U.S.-based cannabis company by market capitalization. The majority of the cannabis unicorns, or those companies with $1+ billion market capitalizations, are licensed producers of medical cannabis in Canada, including Canopy Growth Corp. and Aurora Cannabis Inc.

Investors may want to take a closer look at the stock given its unique reach into diverse U.S. markets and its focus on building a defensible national brand. At the same time, the company efforts to expand into Canada could unlock incremental value for shareholders following recreational legalization later this year.

MedMen Enterprises (CSE:MMEN) represents a compelling opportunity to invest in the cannabis industry. With its growing U.S. footprint, the company offers one of the only truly diversified plays on the U.S. cannabis industry. Meanwhile, its listing on the CSE ensures that investors across North America can easily acquire a piece of the company.

Please follow the link to see the CEO interview read the full article: http://www.cannabisfn.com/cfn-exclusive-interview-medmen-becomes-canadas-next-billion-dollar-cannabis-listing/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com